Dr. Carol Lally Shields, an ocular oncologist, will deliver the 12th annual Emil T. Hofman Lecture at 10 a.m. Sept. 11 (Saturday) in the DeBartolo Hall auditorium. Titled “The Hidden Threat of Eye Cancer,” the lecture is free and open to the public.p. Shields is associate director of the oncology service at Wills Eye Hospital and professor of ophthalmology at Thomas Jefferson University in Philadelphia. Each year the oncology service manages approximately 500 patients with uveal melanoma, 120 patients with retinoblastoma, and numerous other intraocular, orbital and adnexal tumors. A 1979 graduate of Notre Dame and three-time captain of the basketball team, Shields earned her medical degree from the University of Pittsburgh. She completed her residency in ophthalmology at Wills in 1987 and subsequently did fellowship training in ocular oncology, oculoplastic surgery and ophthalmic pathology.p. Shields is the author or co-author of five textbooks, 700 articles in major journals, 142 textbook chapters and has delivered more than 400 lectures. She has received numerous professional awards, including the prestigious Donders Medal, given by the Netherlands Ophthalmologic Society every five years to an ophthalmologist of world fame and outstanding merit. It is one of the most prestigious awards in the field, and Shields is the first woman to be honored.p. The Emil T. Hofman Lecture Series is a medical education program sponsored by Saint Joseph Regional Medical Center in conjunction with the Notre Dame Alumni Association. The series honors the dean emeritus of the First Year of Studies and professor emeritus of chemistry at Notre Dame. It is estimated that Hofman taught more than 32,000 Notre Dame students, including thousands who are now physicians, engineers and scientists.p.
TopicID: 6749